Ikarovec

PITCH

Ikarovec is a pre-clinical phase gene therapy company. Our programmes are aimed at treating common eye diseases. Our technology allows for targeting multiple disease targets and pathways thereby improving efficacy and restoring sight and preventing blindness.

Based in

Canterbury

Created in

> Website

LATEST INVESTMENT

#biotech 06.2020

Ikarovec

£458K

Innovate UK